Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5813)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 28, 2021 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kang YB, Cai Y. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer. World J Gastroenterol 2021; 27(32): 5362-5375 [PMID: 34539138 DOI: 10.3748/wjg.v27.i32.5362] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i32/5362.htm |
| Number | Citing Articles |
| 1 |
Elena Layunta, Berta Buey, Jose Emilio Mesonero, Eva Latorre. Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.748254
|
| 2 |
Ishfaq Hassan Mir, Saqib Hassan, Joseph Selvin, Chinnasamy Thirunavukkarasu. Human Microbiome in Health, Disease, and Therapy. 2023; : 127 doi: 10.1007/978-981-99-5114-7_7
|
| 3 |
Yongbo Kang, Yue Cai, Yanqin Zhao, Ying Yang. The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.979876
|
| 4 |
Shanshan Yang, Suya Zhao, Yixiang Ye, Liqun Jia, Yanni Lou. Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021). Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.952546
|
| 5 |
Jinglong Huang, Caifeng Gong, Aiping Zhou. Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology 2023; 15 doi: 10.1177/17588359231204854
|
| 6 |
Yuqing Zhou, Zhaoxia Liu, Tingtao Chen. Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.847350
|
| 7 |
Sheema Khan, Goutam Banerjee, Saini Setua, Daleniece Higgins Jones, Bhavin V. Chauhan, Anupam Dhasmana, Pratik Banerjee, Murali Mohan Yallapu, Stephen Behrman, Subhash C. Chauhan. Metagenomic analysis unveils the microbial landscape of pancreatic tumors. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1275374
|
| 8 |
Maude Jans, Lars Vereecke. A guide to germ‐free and gnotobiotic mouse technology to study health and disease. The FEBS Journal 2024; doi: 10.1111/febs.17124
|
| 9 |
Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, Kiyoshi Yoshimura. Current Status of Immune Checkpoint Inhibitors in the Broncho-Esophagological Field. Nihon Kikan Shokudoka Gakkai Kaiho 2022; 73(5): 308 doi: 10.2468/jbes.73.308
|
| 10 |
Yong-Bo Kang, Yue Cai. Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”. World Journal of Gastroenterology 2022; 28(20): 2248-2250 doi: 10.3748/wjg.v28.i20.2248
Abstract(525) |
Core Tip(512) |
Full Article(HTML)(1692)
|
Full Article (PDF)-629K(183)
|
Full Article (Word)-102K(105)
|
Audio-176K(1)
|
Peer-Review Report-190K(45)
|
Answering Reviewers-107K(55)
|
Times Cited (0)
|
Total Visits (5201)
|
Open
|
| 11 |
Yongbo Kang, Liping Li, Xing Kang, Yanqin Zhao, Yue Cai. Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies. Clinical Immunology 2022; 245: 109173 doi: 10.1016/j.clim.2022.109173
|
| 12 |
Naoko Ohtani, Tomonori Kamiya, Norifumi Kawada. Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond. Hepatology Communications 2023; 7(9) doi: 10.1097/HC9.0000000000000241
|
| 13 |
Pengya Feng, Xia Xue, Ihtisham Bukhari, Chunjing Qiu, Yingying Li, Pengyuan Zheng, Yang Mi. Gut microbiota and its therapeutic implications in tumor microenvironment interactions. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1287077
|
| 14 |
Yongbo Kang, Yue Cai, Ying Yang. The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies. Liver Cancer 2022; 11(2): 113 doi: 10.1159/000521358
|
| 15 |
Yongbo Kang, Yue Cai. Commentary: Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral Lactobacillus plantarum. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.846379
|
| 16 |
Shanshan Yang, Shaodong Hao, Hui Ye, Xuezhi Zhang. Global research on the crosstalk between intestinal microbiome and colorectal cancer: A visualization analysis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1083987
|